Virtual Medicinal Product (VMP)
-
Erenumab 140mg/1ml solution for injection pre-filled disposable devices
Name Details
Current Name
Erenumab 140mg/1ml solution for injection pre-filled disposable devices
|
Start Date
26-08-2019
|
End Date
|
|
Abbreviated Name
Erenumab 140mg/1ml inj pre-filled disposable devices
|
Start Date
26-08-2019
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N02CD01
BNF |
Current BNF
04070402
|
Start Date
01-02-2023
|
End Date
|
Previous BNF
04070401
|
Start Date
04-04-2022
|
End Date
31-01-2023
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
37617611000001104 |
26-08-2019 |
|
VMP Ingredients
VMP ingredients table
Erenumab |
Based on Ingredient Substance |
|
140 mg |
1 ml |
Name
Erenumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
140
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Erenumab
-
VMP
(Current) Erenumab 140mg/1ml solution for inje...
Virtual Medicinal Product Pack (VMPP) Information